US · Healthcare

Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)

Diagnostics & Research

Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SBLOF

P/E ratio

18.00

Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) — FAQ

What is SBLOF's P/E ratio?

The price-to-earnings (P/E) ratio for Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) is 18.00 (data as of 2026-05-23).

Does Shin Nippon Biomedical Laboratories, Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Shin Nippon Biomedical Laboratories, Ltd. (SBLOF). Check the MyAverix Finance app for the latest dividend data.

What sector is Shin Nippon Biomedical Laboratories, Ltd. in?

Shin Nippon Biomedical Laboratories, Ltd. (SBLOF) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is SBLOF listed on?

SBLOF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)